Davids Secures $34 Million Federal Investment to Grow Kansas City's Biomanufacturing Industry, Create Good-Paying Jobs
manufacturing biologic medicines and cancer therapies, strengthening domestic production of critical medical technologies, and helping new biotechnology companies